GMED 8-K: Buyback

Filed with the SEC on · accession 0001628280-26-071042

GMED filed a 8-K (current report) with the SEC on Nov 5, 2026. Globus Medical's Board of Directors authorized an additional $500 million share repurchase under its existing program, leaving approximately $611 million available for future repurchases. The stock moved -6.5% by the first close after the filing.

Summary of the filing

Globus Medical's Board of Directors authorized an additional $500 million share repurchase under its existing program, leaving approximately $611 million available for future repurchases. The company also reported Q3 2026 sales and operating results via press release.

Key details

Additional share repurchase authorization$500.0M
Remaining availability under repurchase program$611.0M
RegistrantGlobus Medical, Inc.
Chief financial officerKyle R. Kline

How GMED stock reacted

Close before

$87.10

Nov 4, 2026

First close after

-6.50%

$81.44

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for GMED, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for GMED?

Click here

Frequently asked questions

What did GMED file with the SEC on Nov 5, 2026?

GMED filed a 8-K (Buyback). Globus Medical's Board of Directors authorized an additional $500 million share repurchase under its existing program, leaving approximately $611 million available for future repurchases. The company also reported Q3 2026 sales and operating results via press release.

What does a buyback mean for GMED stock?

Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did GMED stock react to this filing?

GMED closed at $87.10 before the filing and $81.44 on Nov 5, 2026 (-6.50%).

Other GMED SEC filings

Get alerts when GMED files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days